Skip to content

    Medi Assist Ser.

    MEDIASSISTGood
    Financial Services·6 Feb 2025
    Management Summary

    Medi Assist Healthcare Services Limited reported strong financial performance for Q3 and 9M FY25, driven by robust growth in Premium Under Management, particularly in the retail segment. The company highlighted its focus on technology for automation and fraud prevention, alongside strategic acquisitions like Paramount TPA. Management expressed confidence in navigating industry dynamics, including medical inflation and competition, by leveraging its operational efficiencies and strong ecosystem partnerships.

    Highlights

    7

    • Total income for 9M FY25 was INR 550 crore, growing 14.3% YoY.

    • Operating revenue for 9M FY25 was INR 534.4 crore, a growth of 40.2% YoY.

    • EBITDA for 9M FY25 was INR 113.4 crore, up 17.7% YoY, with a margin of 21.2% on operating revenue.

    • PAT for 9M FY25 was INR 69.9 crore, a growth of 53.6% YoY, translating to a 12.7% margin on total income.

    • Premium Under Management (PUM) reached INR 15,829 crores as of December 31, 2024, growing 16.6% YoY (adjusted for acquisitions).

    • Retail PUM grew 31% YoY to INR 2,050 crores, contributing to a 60 bps increase in market share to 19.8%.

    • The company processed over 6 million claims in 9M FY25 and added three new private insurance companies to its retail book.

    What Changed2

    vs Q4 FY25

    Guidance items6 → 4 (-2)Risks discussed3 → 4 (+1)

    Key financials

    Single quarter

    09 metrics
    1. 01Total Income₹550 Cr+14.3%YoY
    2. 02Operating Revenue₹534.4 Cr+40.2%YoY
    3. 03EBITDA (excl. Other Income)₹113.4 Cr+17.7%YoY
    4. 04EBITDA Margin (on Operating Revenue)21.2%
    5. 05PAT₹69.9 Cr+53.6%YoY

    Segment breakdown

    Government Business
    10.3% Revenue Contribution
    International Benefits Business
    4.9% Revenue Contribution
    Group PUM
    ₹13,779 Cr PUM14.7% Growth
    Retail PUM
    ₹2,050 Cr PUM31% Growth
    List

    Guidance & targets

    4
    CategoryTargetPriority
    Profitability
    Effective Tax Rate (ETR)
    18-19%
    		High
    Profitability
    Adjusted Quarterly Margin
    22%-odd
    		Medium
    Acquisition
    Paramount TPA Acquisition Completion
    within the current quarter
    		Medium
    Acquisition
    Paramount TPA Top Line Growth
    some amount of growth
    		Low

    Risks & concerns

    6
    RiskSeverity

    Softness in employment numbers impacting Group business growth

    Management noted 'softness in the growth in employment numbers' which affects the Group business segment. — Management acknowledged

    medium

    Vintage drag leading to a spike in incidents as portfolio grows

    Management acknowledged 'vintage drag' causing a spike in incidents but expects it to normalize over time with new lives being added. — Management downplayed

    medium

    Downward pressure in Group pricing due to intense competition and EoM regulations

    An analyst raised concerns about downward pressure on Group pricing; management stated this works in their favor by emphasizing customer experience and loss ratio control. — Analyst acknowledged

    medium

    Industry-wide concerns about claims not being in control for retail-focused insurers

    An analyst highlighted industry complaints about uncontrolled claims; management responded by emphasizing their focus on fraud prevention, medical inflation management, and superior claims experience. — Analyst acknowledged

    medium

    Areas of Evasion(2)

    • Exact timing and usage of fundraise (due to regulatory limitations)
    • Detailed pro forma numbers for Paramount TPA (due to limited public information)

    Q&A highlights

    3

    “On the Deferred Tax Asset, there was a reversal on account of the Raksha merger, the approval of which we got during December. As a result of which, there was a one-time reversal on the deferred tax liability which we had created when we acquired Raksha. So, this was a one-time benefit which we got during the quarter, the impact of which happens to be roughly around 8-odd crores for the quarter as such. The ETR for the same reason stands at roughly around 14%. We, however, believe that for the full year, it will bounce back to 18 to 19-odd percentage by March 2025. ... from time to time, the Company keeps evaluating its capital structure and capital allocation strategy. Satish did mention in his opening remarks that we see a very favorable environment for future growth opportunities. ... as per the LODR, we are not able to comment on timing and exact usage, but it will be updated.”

    Reveals a one-time DTA benefit impacting ETR and clarifies the strategic rationale for fundraise while adhering to disclosure limitations.

    asked by Madhukar Ladha, Nuvama Wealth Management

    2 min read6 chapters

    Detailed Narrative

    01

    Q3 & 9M FY25 Financial Performance Overview

    Medi Assist reported a total income of INR 550 crore for the nine months ended December 31, 2024, marking a 14.3% year-on-year growth. Operating revenue, excluding other income, stood at INR 534.4 crore, demonstrating a robust 40.2% growth over the same period last year. EBITDA for the nine months was INR 113.4 crore, up 17.7% YoY, with a healthy margin of 21.2% on operating revenue. Net profit after tax (PAT) grew significantly by 53.6% YoY to INR 69.9 crore, achieving a 12.7% margin on total income.

    02

    Premium Under Management (PUM) and Market Share Growth

    The company's Premium Under Management (PUM) reached INR 15,829 crores as of December 31, 2024, reflecting a 16.6% year-on-year growth after adjusting for acquired companies. Group PUM grew by approximately 14.7-15% to INR 13,779 crores, while Retail PUM showed a strong 31% year-on-year growth, reaching INR 2,050 crores. This performance contributed to a 60 basis points increase in market share, bringing Medi Assist's share of health insurance premium administered to 19.8% as of December 2023.

    03

    Operational Efficiency and Technology Initiatives

    Medi Assist continues to prioritize customer experience and operational efficiency, processing over 6 million claims in the nine months of FY25. The company has established 'hubs of excellence' for claims processing to enhance efficiency and comply with master circular requirements. Technology remains a core focus, with initiatives like 'Raksha Prime' minimizing discharge wait times for over 65,000 patients and the 'Maven Fraud Detection Engine' delivering 2.5x year-on-year growth in savings for insurers through fraud prevention.

    04

    Paramount Acquisition and Capital Strategy

    The acquisition of Paramount TPA, signed in August 2024, is awaiting regulatory approvals and is expected to conclude within the current quarter (Q4 FY25). Paramount TPA reported a top line of INR 153 crores in FY24 with a single-digit adjusted EBITDA margin, and Medi Assist expects some growth on these numbers. The company is also evaluating its capital structure and allocation strategy, noting a favorable environment for future growth opportunities, though specific details on fundraise timing and usage are currently under regulatory disclosure limitations.

    05

    Industry Tailwinds and Government Focus on Healthcare

    Management highlighted positive industry tailwinds, including the Union Government's increased focus on health insurance and healthcare penetration in India. The raising of FDI limits to 100% in the insurance sector and the proposed healthcare coverage for gig workers under PM Jan Arogya Yojana were cited as significant steps. These developments are expected to provide a stronger foundation for the future growth of India's health insurance industry.

    06

    Addressing Industry Challenges and TPA's Role

    Medi Assist addressed concerns regarding medical inflation, vintage drag, and competitive pressure in Group pricing. Management asserted that their focus on fraud, waste, and abuse prevention, technology, and network pricing helps control medical inflation, keeping it below 5% in their portfolio. They emphasized that TPAs play a critical role in improving policyholder experience and delivering value to insurers, with more insurers partnering with Medi Assist, including three new private insurers added in the retail book.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.